|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/21/2024 |
$27.92 |
$27.99 |
$26.91 |
$26.97 |
2.04M | 03/22/2024 |
$27.05 |
$27.49 |
$26.75 |
$27.29 |
1.90M | 03/25/2024 |
$27.37 |
$27.57 |
$27.22 |
$27.31 |
907.60K | 03/26/2024 |
$27.45 |
$27.50 |
$26.76 |
$26.78 |
1.35M | 03/27/2024 |
$27.02 |
$27.29 |
$26.99 |
$27.25 |
1.46M |
|
Alkermes is a biopharmaceutical company. Co. has a portfolio of commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of product candidates in development for neurological disorders and cancer. Co.'s proprietary products include: ARISTADA, which is an extended-release intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO, which utilizes Co.'s proprietary LinkeRx and NanoCrystal technologies; and LYBALVI, which is an oral atypical antipsychotic drug approved in the U.S. for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder. | |
|
Alkermes (ALKS) has the following price history information. Looking back at ALKS historical stock prices for the last five trading days, on March 21, 2024, ALKS opened at $27.92, traded as high as $27.99 and as low as $26.91, and closed at $26.97. Trading volume was a total of 2.04M shares. On March 22, 2024, ALKS opened at $27.05, traded as high as $27.49 and as low as $26.75, and closed at $27.29. Trading volume was a total of 1.90M shares. On March 25, 2024, ALKS opened at $27.37, traded as high as $27.57 and as low as $27.22, and closed at $27.31. Trading volume was a total of 907.60K shares. On March 26, 2024, ALKS opened at $27.45, traded as high as $27.50 and as low as $26.76, and closed at $26.78. Trading volume was a total of 1.35M shares. On March 27, 2024, ALKS opened at $27.02, traded as high as $27.29 and as low as $26.99, and closed at $27.25. Trading volume was a total of 1.46M shares.
ALKS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Alkermes shares, starting with a $10,000 purchase of ALKS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$44.09 |
|
End price/share: |
$27.25 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-38.19% |
|
Average Annual Total Return: |
-4.70% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$6,179.97 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
03/21/2024 | $26.97 | 03/22/2024 | $27.29 | 03/25/2024 | $27.31 | 03/26/2024 | $26.78 | 03/27/2024 | $27.25 |
|
|